Based in Oxford, England, Oxford Sciences Innovation (OSI) specializes in investments in spin-outs from Oxford University’s technology, mathematical, physical, life sciences and medical sciences departments.
OSI has raised £580 million ($706 million), with first-round investors including Google Ventures and the Wellcome Trust and the second round led by Asian investors. Since its foundation in April 2015, the organization has provided financial support to 22 companies, including biotech spinouts Evox, Vaccitech and DJS Antibodies.
Oxford Investment Consultants LLP
Oxford Investment Consultants LLP is an investment advisor that covers life sciences, healthcare and technology in the United Kingdom. The firm prefers to make investments in the University of Oxford spin out companies. Oxford Investments Consultants LLP is based in the United Kingdom.
TheraNova is an experienced medical device developer with a track record of creating innovative and practical solutions to large markets with unmet needs.
TheraNova pursues a rapid, highly capital-efficient process incorporating all the needed elements of medical device development in a shared services model. Since its inception in 2005, TheraNova has been able to generate clinical data within a year of funding and with less than $1M in financing.
Founded in 2012, Exscientia is the leading pharmatech company and the first to automate drug discovery. As a full stack AI drug discovery company, Exscientia generates its own data before combining the analytical power of AI with the creativity and expertise of world-class scientists. This allows Exscientia to shorten the pre-clinical drug discovery stage by at least three-quarters and, in turn, substantially accelerate the delivery of new treatments to patients worldwide.
Oxford Nanopore Technologies has developed the world’s first and only nanopore DNA sequencer, the MinION. The MinION is a portable, real time, long-read, low cost device that has been designed to bring easy biological analyses to anyone, whether in scientific research, education or a range of real world applications such as disease/pathogen surveillance, environmental monitoring, food chain surveillance, self-quantification or even microgravity biology. Commercially available since 2015, the MinION is in use by a thriving community in more than 50 countries, enabling myriad applications within the traditional laboratory environment and in the field.